Logo-apb
Adv Pharm Bull. 2023;13(3): 539-550. doi: 10.34172/apb.2023.050
PMID: 37646049        PMCID: PMC10460814

Research Article

Combined Treatment of Dendrosomal-Curcumin and Daunorubicin Synergistically Inhibit Cell Proliferation, Migration and Induce Apoptosis in A549 Lung Cancer Cells

Seyed Sadegh Eslami 1,2 ORCID, Davod Jafari 1,2 ORCID, Abbas Ghotaslou 3, Moein Amoupour 2, Amir Asri Kojabad 3, Rasool Jafari 4, Navid Mousazadeh 5, Parastoo Tarighi 2 * ORCID, Majid Sadeghizadeh 6 * ORCID

Cited by CrossRef: 1


1- Wang S, Chen H, Guo Z, Benariba M, Li M, Feng N, Wang X, Zhang Y, Zhou N. Tetrahedral DNA Nanostructures as Multifunctional Drug-Delivery Vehicles for Treating Non-Small Cell Lung Cancer. ACS Appl Nano Mater. 2024; [Crossref]
2- Jalilian E, Abolhasani-Zadeh F, Afgar A, Samoudi A, Zeinalynezhad H, Langroudi L. Neutralizing tumor-related inflammation and reprogramming of cancer-associated fibroblasts by Curcumin in breast cancer therapy. Sci Rep. 2023;13(1) [Crossref]
3- Ünlü İ, Özdemir İ, Öztürk Ş, Tuncer M. Effects of Curcumin and Doxorubicin on the Viability of Neuroblastoma Cancer Cell Line. J Cukurova Anesth Surg. 2024;7(3):191 [Crossref]